Clinical Trial Detail

NCT ID NCT04005690
Title Cobimetinib or Olaparib in Treating Patients With Resectable Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

pancreatic adenocarcinoma

Therapies

Olaparib

Cobimetinib

Age Groups: senior adult

No variant requirements are available.